Page last updated: 2024-09-04

ruboxistaurin and Bone Loss, Osteoclastic

ruboxistaurin has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lu, X; Luo, S; Pang, C; Qin, H; Wen, L; Zhang, X; Zhu, B1

Other Studies

1 other study(ies) available for ruboxistaurin and Bone Loss, Osteoclastic

ArticleYear
Ruboxistaurin maintains the bone mass of subchondral bone for blunting osteoarthritis progression by inhibition of osteoclastogenesis and bone resorption activity.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 131

    Topics: Animals; Bone Density; Bone Remodeling; Bone Resorption; Cells, Cultured; Disease Progression; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Femur; Indoles; Male; Maleimides; Mice; Mice, Inbred C57BL; Osteoarthritis; Osteoclasts; Osteogenesis

2020